What sector does Novo Nordisk A/S (NVO) operate in?
Novo Nordisk A/S belongs to the Healthcare sector and operates in the Drug Manufacturers - General industry.
What is Novo Nordisk A/S (NVO) current stock price?
As of the latest data, Novo Nordisk A/S stock price is $37.96, with a previous close of $38.02. Novo Nordisk A/S lost -$0.06 in the last trading session, representing a -0.16% loss.
What is Novo Nordisk A/S (NVO) current market capitalization?
Novo Nordisk A/S market cap is approximately 127.88 billion.
What is Novo Nordisk A/S (NVO) Earnings Per Share (EPS)?
The trailing EPS is $3.55, and the forward EPS is $21.64.
What is Novo Nordisk A/S (NVO) Price-to-Earnings (P/E) ratio?
Novo Nordisk A/S current P/E ratio is 10.69, with a forward P/E of 1.75.
What is Novo Nordisk A/S (NVO) EBITDA?
Novo Nordisk A/S EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 37.14 billion.
Does Novo Nordisk A/S (NVO) pay dividends?
Yes. Novo Nordisk A/S pays semiannual dividends with an annualized yield of 4.9% and an estimated annual payout of $1.86 per share.
When is the next ex-dividend date for Novo Nordisk A/S (NVO)?
The next ex-dividend date is scheduled for March 30, 2026.
How did Novo Nordisk A/S (NVO) perform in its most recent earnings report?
In the last report (December 31, 2025), Novo Nordisk A/S posted an EPS surprise of 2.37% and a revenue surprise of -74.49%.
When is Novo Nordisk A/S (NVO) next earnings report?
Novo Nordisk A/S is expected to release its next earnings report on March 31, 2026.
What is Novo Nordisk A/S (NVO) beta (volatility) score?
Novo Nordisk A/S has a beta of 0.265, indicating lower volatility than the overall market.
